Indications and uses
healthcare personnel handwash : helps reduce bacteria that potentially can cause disease skin wound and general skin cleaning
Antiseptic Skin Cleanser
- Manufacturer
- Xttrium Laboratories, Inc.
- Effective date
- 2020-10-12
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 7
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:12:02
Label at a glance#
ProductAntiseptic Skin Cleanser
Active ingredientCHLORHEXIDINE GLUCONATE
Label structure10 sections
Dosage and administration
use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns. Healthcare personnel handwash: wet hands with water dispense about 5ml of product into cupped hands and wash in vigorous manner for about 15 seconds rinse and dry thoroughly Skin wound and normal skin cleansing: thoroughly rinse the area to be cleaned with water apply the minimum amount of pr...
Storage and handling
store at 20°-25° C (68°-77° F) avoid excessive heat above 40° C (104° F)
Contacts and useful links#
Websitewww.p65warnings.gov
www.P65Warnings.gov
www.P65Warnings.govLabel contents#
Full prescribing information#
Active Ingredients
Chlorhexidine Gluconate 4% Solution
Purpose
Antiseptic
Uses
healthcare personnel handwash: helps reduce bacteria that potentially can cause disease
skin wound and general skin cleaning
Warnings
For external use only
Allergy alert:
This product may cause a severe allergic reaction. Symptoms may include:
wheezing/difficulty breathing
- shock
- facial swelling
- hives
- rash
If an allergic reaction occurs, stop use and seek medical help right away
Do not use
- if you or the patient is allergic to chlorhexidine gluconate or any other ingredient in this product
- in contact with meninges
- in the genital area
When using this product
- keep out of eyes, ears, and mouth. May cause serious and permanent eye injury if permitted to enter and remain in the eye or may cause deafness when instilled in the middle ear through perforated eardrums.
- if solution should contact these areas, rinse out promptly and thoroughly with water
- wounds which involve more than the superficial layers of the skin should not be routinely treated
- repeated general skin cleansing of large body areas should not be done except when advised by a healthcare provider
Stop use and ask doctor if
irritation, sensitization, or allergic reaction occurs. These may be signs of a serious condition.
Keep out of reach of children
If swallowed, get medical help or contact a Poison Control Center right away
Warning
This product contains a chemical known to the State of California to cause cancer.
Directions
- use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns.
Healthcare personnel handwash:
- wet hands with water
- dispense about 5ml of product into cupped hands and wash in vigorous manner for about 15 seconds
- rinse and dry thoroughly
Skin wound and normal skin cleansing:
- thoroughly rinse the area to be cleaned with water
- apply the minimum amount of product necessary to cover the skin or wound area and wash gently
- rinse again thoroughly
Other information
- store at 20°-25° C (68°-77° F)
- avoid excessive heat above 40° C (104° F)
Inactive ingredients
cocamide DEA, fragrance, glucono-delta-lactone, hydroxyethylcellulose, isopropyl alcohol, lauramine oxide, PEG-75 lanolin, purified water, tridecyl alcohol.
Questions of comments?
call 1-800-587-3721 Monday through Friday 8:00 AM to 4:30 PM CST.
OTHER SAFETY INFORMATION
Warning: This product can expose you to coconut oil diethanolamine condensate (cocamide diethanolamine), which is known to the State of California to cause cancer. For more information go to www.P65Warnings.gov
Laundering/Cleaning Instructions: Chlorhexidine gluconate skin cleansers will cause stains if used with chlorine releasing products. Rinse completely and use only non-chlorine detergents.
*This product is not manufactured or distributed by Mölnlycke Healthcare, owner of the registered trademark Hibiclens®.
Package label and principal display panel
Premier Value
COMPARE TO THE ACTIVE INGREDIENT IN HIBICLENS®
Antiseptic Skin Cleanser
ANTISEPTIC/ANTIMICROBIAL SKIN CLEANSER
(Chlorhexidine Gluconate 4% Solution)
FOR EXTERNAL USE ONLY
DYE FREE
DO NOT USE IF SAFETY SEAL IS BROKEN OR MISSING
8 fl oz (237 mL)
Premier Value
COMPARE TO THE ACTIVE INGREDIENT IN HIBICLENS®
Antiseptic Skin Cleanser
ANTISEPTIC/ANTIMICROBIAL SKIN CLEANSER
(Chlorhexidine Gluconate 4% Solution)
FOR EXTERNAL USE ONLY
DYE FREE
DO NOT USE IF SAFETY SEAL IS BROKEN OR MISSING
16 fl oz (473 mL)
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Antiseptic Skin Cleanser
- Chlorhexidine Gluconate 4%
- COCO DIETHANOLAMIDE
- PEG-75 LANOLIN
- HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)
- ISOPROPYL ALCOHOL
- WATER
- TRIDECYL ALCOHOL
- GLUCONOLACTONE
- CHLORHEXIDINE GLUCONATE
- CHLORHEXIDINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0116-0228 | 0116-0228-00, 0116-0228-16 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| COCO DIETHANOLAMIDE | 92005F972D | IACT |
| PEG-75 LANOLIN | 09179OX7TB | IACT |
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | S38J6RZN16 | IACT |
| ISOPROPYL ALCOHOL | ND2M416302 | IACT |
| WATER | 059QF0KO0R | IACT |
| TRIDECYL ALCOHOL | 8I9428H868 | IACT |
| GLUCONOLACTONE | WQ29KQ9POT | IACT |
| CHLORHEXIDINE GLUCONATE | MOR84MUD8E | ACTIB |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019125-001 | DYNA-HEX 4 | CHLORHEXIDINE GLUCONATE | 4% | SOLUTION / TOPICAL | 1984-12-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N019125-001 | DYNA-HEX 4 | 4% | SOLUTION / TOPICAL | 1984-12-24 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N019125-001 | DYNA-HEX 4 | 4% | SOLUTION / TOPICAL | 1984-12-24 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N019125-001 | EXIDINE | 4% | SOLUTION / TOPICAL | 1984-12-24 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5074a8eb-62c3-2ec6-e063-6394a90a0926 | 4ab2dd27-c584-0e49-e054-00144ff88e88 | 2026-04-27 | Warnings | 4ab2dd27-c584-0e49-e054-00144ff88e88 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.